Product Information
TOPIRAMATE 25 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0254 per EA under NDC 76282027860. Its NADAC has been published 290 times since Dec 9, 2020.
Strength
25 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282027860
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TOPIRAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA079162On Market Since
9/7/2020
Pharmacological Classes
Price Statistics
The NADAC for TOPIRAMATE 25 MG TABLET has been published 290 times since Dec 9, 2020, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0254 per EA |
|---|---|
| All-time high | $0.0354 (Jun 14, 2023) |
| All-time low | $0.0221 (Jul 17, 2024) |
| 52-week high | $0.0271 |
| 52-week low | $0.0254 |
| Median price | $0.0311 |
| Average price | $0.0304 |
| Largest weekly change | -29.1% (Jul 17, 2024) |
| Weeks tracked | 290 |
| Tracking since | Dec 9, 2020 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOPIRAMATE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 25 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0254 per EA (NDC 76282027860), effective Jun 24, 2026.
How has the price of TOPIRAMATE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOPIRAMATE 25 MG TABLET has declined 25.5%. It has been tracked across 290 weekly CMS publications since Dec 9, 2020.
What are the highest and lowest recorded NADAC prices for TOPIRAMATE 25 MG TABLET?
Since Dec 9, 2020, the NADAC for TOPIRAMATE 25 MG TABLET has ranged from a low of $0.0221 (Jul 17, 2024) to a high of $0.0354 (Jun 14, 2023), with a median of $0.0311 per EA.
Are there cheaper alternatives to TOPIRAMATE 25 MG TABLET?
13 NADAC-published products share the same active ingredient, strength, and dosage form as TOPIRAMATE 25 MG TABLET, but none are currently priced below it.
Who manufactures TOPIRAMATE 25 MG TABLET?
TOPIRAMATE 25 MG TABLET (NDC 76282027860) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification